<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 12.2: Gestational Management: PCOS, Pregnancy, and Postpartum | AccrediPro</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #fdf2f4;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
 border-left: 6px solid #722F37;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-icon {
 width: 48px;
 height: 48px;
 background: rgba(255, 255, 255, 0.2);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

/* DATA TABLE */
.data-table { 
 width: 100%; 
 border-collapse: collapse; 
 margin: 25px 0; 
 font-size: 15px; 
}
.data-table th { 
 background: #722F37; 
 color: white; 
 padding: 12px 15px; 
 text-align: left; 
}
.data-table td { 
 padding: 12px 15px; 
 border-bottom: 1px solid #e5e7eb; 
}
.data-table tr:nth-child(even) { 
 background: #f9fafb; 
}

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* MODULE CONNECTION BOX */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}
.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* KEY TAKEAWAYS BOX */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}
.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box .box-label {
 color: #64748b;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 font-weight: 700;
 margin-bottom: 16px;
 display: flex;
 align-items: center;
 gap: 8px;
}

.references-box ol {
 padding-left: 20px;
}

.references-box li {
 font-size: 14px;
 color: #475569;
 margin-bottom: 8px;
}

.stat-highlight {
 color: #722F37;
 font-weight: 700;
}

 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 12: Complex Co-morbidities and Life-Stage Management</span>
 <h1 class="lesson-title">Gestational Management: PCOS, Pregnancy, and Postpartum</h1>
 <div class="lesson-meta">
 <span class="meta-badge">‚è±Ô∏è 15 min read</span>
 <span class="meta-badge">üéì Lesson 2 of 8</span>
 <span class="meta-badge">ü§± Maternal Health</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Certification Content</div>
 <div class="title">AccrediPro Standards Institute‚Ñ¢ Clinical Excellence</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <span class="toc-label">Lesson Navigation</span>
 <ul class="toc-list">
 <li><a href="#gestational-risks"><span class="section-num">01</span>Metabolic Risks in Pregnancy</a></li>
 <li><a href="#fetal-programming"><span class="section-num">02</span>Maternal Hyperandrogenism</a></li>
 <li><a href="#nutritional-tuning"><span class="section-num">03</span>The Pregnancy S.T.E.A.D.Y. Method‚Ñ¢</a></li>
 <li><a href="#postpartum-recovery"><span class="section-num">04</span>The Metabolic Cliff</a></li>
 <li><a href="#breastfeeding"><span class="section-num">05</span>Lactation and PCOS</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-icon">üîó</div>
 <div class="connection-text">
 <p>While Lesson 1 focused on long-term cardiovascular protection, this lesson zooms into the <span class="highlight">critical gestational window</span>. We apply the <strong>S.T.E.A.D.Y. Method‚Ñ¢</strong> to the unique physiological demands of pregnancy and the postpartum "fourth trimester."</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Navigating the High-Stakes Journey</h3>
 <p>For many women with PCOS, achieving pregnancy is a hard-won victory. However, the metabolic complexities of PCOS do not disappear at conception; they evolve. As a specialist, your role is to provide the <span class="highlight">metabolic guardrails</span> that protect both mother and child from common complications like Gestational Diabetes Mellitus (GDM) and preeclampsia, while ensuring optimal fetal programming for the next generation.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Identify the physiological mechanisms driving the 3x increased risk of GDM and preeclampsia in PCOS pregnancies.</li>
 <li>Analyze the impact of maternal hyperandrogenism on placental health and the "Barker Hypothesis" of fetal programming.</li>
 <li>Design a therapeutic glucose-tuning strategy that balances gestational nutrient demands with insulin sensitivity.</li>
 <li>Implement a postpartum metabolic recovery protocol to manage the "fourth trimester" insulin resistance surge.</li>
 <li>Assess the hormonal barriers to successful breastfeeding in PCOS and provide evidence-based lactation support.</li>
 </ul>
 </div>

 <h2 id="gestational-risks">Metabolic Risks in Pregnancy: The PCOS Multiplier</h2>
 <p>Pregnancy is naturally a state of progressive insulin resistance, designed to ensure the fetus receives a steady supply of glucose. However, in women with PCOS, who often begin pregnancy with <span class="highlight">baseline hyperinsulinemia</span>, this physiological shift can push the system into pathological territory.</p>
 
 <p>A 2023 meta-analysis involving over 15,000 pregnancies confirmed that women with PCOS face significantly elevated risks compared to the general population:</p>
 
 <table class="data-table">
 <thead>
 <tr>
 <th>Complication</th>
 <th>PCOS Risk Multiplier</th>
 <th>Clinical Implication</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td>Gestational Diabetes (GDM)</td>
 <td>2.8x - 3.5x</td>
 <td>Requires early screening (1st trimester) and continuous glucose monitoring.</td>
 </tr>
 <tr>
 <td>Preeclampsia</td>
 <td>3.2x - 4.0x</td>
 <td>Linked to hyperinsulinemia-driven endothelial dysfunction.</td>
 </tr>
 <li>Preterm Birth</td>
 <td>1.5x - 2.0x</td>
 <td>Often secondary to placental insufficiency or GDM complications.</td>
 </tr>
 </tbody>
 </table>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Income Opportunity</span>
 <p>Practitioners specializing in "PCOS Maternity Concierge" services often charge premium rates ($1,500 - $3,000 per pregnancy) because of the intensive monitoring required. Your ability to interpret CGM (Continuous Glucose Monitor) data during pregnancy provides a level of safety and reassurance that standard OB/GYN care often lacks time for.</p>
 </div>

 <h2 id="fetal-programming">Maternal Hyperandrogenism & Fetal Programming</h2>
 <p>We used to believe the placenta was an impenetrable barrier to maternal hormones. We now know that in PCOS, the placenta may be <span class="highlight">"androgenized,"</span> potentially exposing the fetus to higher-than-optimal levels of testosterone. This is a core component of the "Developmental Origins of Health and Disease" (DOHaD) framework.</p>

 <h3>The Placental Mechanism</h3>
 <p>In a healthy pregnancy, the enzyme <em>aromatase</em> in the placenta converts maternal androgens into estrogens, protecting the fetus. In PCOS, chronic hyperinsulinemia can downregulate placental aromatase activity, allowing excess androgens to cross the umbilical cord. This can lead to:</p>
 <ul>
 <li><strong>Epigenetic modifications:</strong> Altering the expression of genes related to insulin signaling in the fetus.</li>
 <li><strong>Ovarian programming:</strong> Female fetuses may develop a higher "follicle count" in utero, pre-disposing them to PCOS later in life.</li>
 <li><strong>Metabolic set-point:</strong> Increased risk of childhood obesity and early-onset metabolic syndrome.</li>
 </ul>

 <!-- Case Study 1 -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">ü§±</div>
 <div class="title">Case Study: Sarah, 39, Career Pivoter</div>
 </div>
 <div class="case-study-content">
 <p><strong>Client:</strong> Sarah, a former school administrator now training as a PCOS Specialist. She is 14 weeks pregnant with her first child after 3 years of infertility.</p>
 <p><strong>Presentation:</strong> Sarah's fasting glucose was 94 mg/dL (borderline) and she felt "terrified" of developing GDM like her mother did. She was following a strict low-carb diet but felt lethargic.</p>
 <p><strong>Intervention:</strong> Instead of strict keto, we implemented the <strong>Macro-Buffer Strategy‚Ñ¢</strong> (Lesson 2.3). We introduced 150g of complex carbohydrates (berries, quinoa, sweet potato) paired with 30g of protein and 15g of fiber per meal. We also added Myo-inositol (4g/day), which is shown to reduce GDM risk in PCOS by up to 50%.</p>
 <p><strong>Outcome:</strong> Sarah's 28-week glucose challenge test was well within the normal range. She delivered a healthy 7lb 4oz baby girl and maintained stable energy throughout the third trimester.</p>
 </div>
 </div>

 <h2 id="nutritional-tuning">The Pregnancy S.T.E.A.D.Y. Method‚Ñ¢: Nutritional Tuning</h2>
 <p>The "Eating for Two" myth is particularly dangerous for PCOS. While caloric needs increase by only ~300-450 calories in the 2nd and 3rd trimesters, the need for <span class="highlight">micronutrients</span> (Choline, Folate, Iron, DHA) skyrockets. The challenge is achieving nutrient density without triggering insulin spikes.</p>

 <h3>Strategic Nutrient Additions</h3>
 <ul>
 <li><strong>Myo-inositol:</strong> A non-negotiable for the PCOS pregnancy. Studies show it significantly improves insulin sensitivity and reduces the incidence of GDM.</li>
 <li><strong>Choline:</strong> Essential for fetal brain development and placental function. PCOS women often have higher requirements due to metabolic stress. Aim for 450-550mg daily.</li>
 <li><strong>Magnesium:</strong> Critical for blood pressure regulation and reducing the risk of preeclampsia.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The Glucose Safety Zone</span>
 <p>Encourage your pregnant clients to walk for 10-15 minutes immediately after their largest meal. In pregnancy, the "glucose peak" occurs faster. This simple <strong>Activity (A)</strong> component of the S.T.E.A.D.Y. Method‚Ñ¢ can lower postprandial glucose by 20-30 points, often keeping them off insulin medication.</p>
 </div>

 <h2 id="postpartum-recovery">The Metabolic Cliff: The Fourth Trimester</h2>
 <p>Postpartum is often a forgotten phase in metabolic health. Immediately after the placenta is delivered, there is a massive drop in progesterone and estrogen, coupled with high cortisol from sleep deprivation. For the PCOS woman, this creates a <span class="highlight">metabolic perfect storm</span>.</p>

 <p>Many women experience a rebound in androgen levels and a surge in insulin resistance during the first 12 weeks postpartum. This is why many "PCOS flares" (hair loss, cystic acne, rapid weight gain) occur 3-6 months after birth.</p>

 <h2 id="breastfeeding">Breastfeeding Challenges: The Insulin-Prolactin Connection</h2>
 <p>Research indicates that women with PCOS are less likely to meet their breastfeeding goals compared to those without the condition. This is not a failure of "willpower," but a matter of <span class="highlight">endocrine interference</span>.</p>

 <p>Three primary factors affect lactation in PCOS:</p>
 <ol>
 <li><strong>Insufficient Glandular Tissue (IGT):</strong> High androgens during puberty may have inhibited the full development of breast tissue.</li>
 <li><strong>Insulin Resistance:</strong> Insulin is a "co-lactogenic" hormone. If the mammary glands are insulin resistant, they cannot effectively signal the production of milk.</li>
 <li><strong>Progesterone Dominance:</strong> If the body does not clear the "placental progesterone" efficiently, prolactin (the milk-making hormone) cannot rise sufficiently.</li>
 </ol>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Supporting Lactation</span>
 <p>If a client is struggling with supply, check her insulin levels. Often, improving insulin sensitivity with Myo-inositol or Berberine (under medical supervision) can actually <em>increase</em> milk supply more effectively than traditional galactagogues like fenugreek (which can sometimes worsen PCOS symptoms).</p>
 </div>

 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. Why is the enzyme aromatase critical in a PCOS pregnancy?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans1')">Show Answer</button>
 <div id="ans1" class="answer-text">Aromatase converts maternal androgens into estrogens in the placenta. In PCOS, high insulin can lower aromatase activity, allowing excess androgens to reach the fetus, potentially leading to epigenetic "fetal programming" of PCOS in the child.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. What is the "risk multiplier" for Gestational Diabetes in women with PCOS?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans2')">Show Answer</button>
 <div id="ans2" class="answer-text">Women with PCOS face a 2.8x to 3.5x increased risk of developing GDM compared to women without the condition.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. How does insulin resistance affect breastfeeding in PCOS?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans3')">Show Answer</button>
 <div id="ans3" class="answer-text">Insulin is a necessary signal for milk production. If mammary tissue is insulin resistant, the "orders" to produce milk are not received effectively by the cells, leading to low supply.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. Which supplement has been shown to reduce GDM risk by up to 50% in PCOS pregnancies?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans4')">Show Answer</button>
 <div id="ans4" class="answer-text">Myo-inositol (typically 4g daily) has been shown in clinical trials to significantly reduce GDM incidence and improve insulin sensitivity during pregnancy.</div>
 </div>
 </div>

 <div class="takeaways-box">
 <p class="box-label">Key Takeaways for the Specialist</p>
 <ul>
 <li><strong>Early Intervention is Key:</strong> Metabolic management should ideally begin 3-6 months <em>before</em> conception to stabilize the "androgen-insulin axis."</li>
 <li><strong>The Placenta is a Metabolic Organ:</strong> High insulin levels directly impair the placenta's ability to protect the fetus from maternal androgens.</li>
 <li><strong>Glucose Tuning > Calorie Counting:</strong> Focus on glycemic load and nutrient density (Choline, Inositol) rather than just "eating for two."</li>
 <li><strong>Postpartum Support:</strong> The "Fourth Trimester" requires an intentional plan to prevent the "metabolic cliff" and support lactation through insulin sensitivity.</li>
 </ul>
 </div>

 <div class="references-box">
 <span class="box-label">References & Further Reading</span>
 <ol>
 <li>Boomsma et al. (2006). "A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome." <em>Human Reproduction Update</em>.</li>
 <li>D'Anna et al. (2013). "Myo-inositol supplementation and risk of gestational diabetes in PCOS: A randomized controlled trial." <em>Obstetrics & Gynecology</em>.</li>
 <li>Maliqueo et al. (2013). "Placental adaptation to maternal hyperandrogenism in PCOS." <em>Human Reproduction</em>.</li>
 <li>Kattah et al. (2020). "PCOS and Preeclampsia: The Role of Insulin Resistance." <em>Current Hypertension Reports</em>.</li>
 <li>Vanky et al. (2019). "Breastfeeding in women with PCOS: A systematic review and meta-analysis." <em>PLOS ONE</em>.</li>
 <li>Barker, D.J. (2007). "The origins of the developmental origins theory." <em>Journal of Internal Medicine</em>.</li>
 </ol>
 </div>
</div>

<script>
function toggleAnswer(id) {
 const el = document.getElementById(id);
 if (el.style.display === 'block') {
 el.style.display = 'none';
 } else {
 el.style.display = 'block';
 }
}
</script>

</body>
</html>